Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 11:59 am Purchase |
2025-03-31 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
4,497,035 7.400% |
116,653 (+2.66%) |
Filing History |
| 2025-05-14 10:47 am Purchase |
2025-03-31 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Investment Management, Inc. | 3,053,824 5.000% |
1,288,782 (+73.02%) |
Filing History |
| 2025-05-12 10:24 am Sale |
2025-03-31 | 13G | Ascendis Pharma A/S ASND |
FMR LLC | 4,646,943 8.000% |
-467,426 (-9.14%) |
Filing History |
| 2025-02-14 11:54 am Purchase |
2024-12-31 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
4,380,382 7.200% |
193,688 (+4.63%) |
Filing History |
| 2025-02-11 09:15 am Purchase |
2024-12-31 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LP | 5,528,239 9.180% |
1,453,025 (+35.66%) |
Filing History |
| 2025-02-10 5:13 pm Purchase |
2024-12-31 | 13G | Ascendis Pharma A/S ASND |
WESTFIELD CAPITAL MANAGEMENT CO LP | 4,075,214 9.180% |
44,580 (+1.11%) |
Filing History |
| 2024-11-14 5:46 pm Sale |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
RA CAPITAL MANAGEMENT L.P. | 9,710,428 16.100% |
-396,972 (-3.93%) |
Filing History |
| 2024-11-14 2:57 pm Purchase |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
4,186,694 7.000% |
191,909 (+4.80%) |
Filing History |
| 2024-11-14 1:28 pm Sale |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Investment Management, Inc. | 1,765,042 2.900% |
-2,224,788 (-55.76%) |
Filing History |
| 2024-11-14 09:31 am Purchase |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
Avoro Capital Advisors LLC | 4,988,888 8.200% |
1,233,333 (+32.84%) |
Filing History |
| 2024-11-12 09:51 am Sale |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
Artisan Partners Asset Management Inc. | 4,411,111 7.300% |
-1,338,116 (-23.27%) |
Filing History |
| 2024-11-08 10:34 am Sale |
2024-09-30 | 13G | Ascendis Pharma A/S ASND |
Wellington Management Group LLP | 1,261,480 2.210% |
-1,986,813 (-61.16%) |
Filing History |
| 2024-02-16 4:29 pm Sale |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Associates, Inc. | 1,444,950 2.500% |
-9,424,610 (-86.71%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
RA CAPITAL MANAGEMENT L.P. | 10,107,400 17.500% |
140,228 (+1.41%) |
Filing History |
| 2024-02-14 4:21 pm Sale |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
Baker Bros. Advisors LP | 0 0.000% |
-4,954,855 (Position Closed) |
Filing History |
| 2024-02-14 10:04 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Investment Management, Inc. | 3,989,830 6.900% |
3,989,830 (New Position) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
T. Rowe Price Associates, Inc. | 10,869,560 2.500% |
7,159,719 (+192.99%) |
Filing History |
| 2024-02-14 09:17 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
Avoro Capital Advisors LLC | 3,755,555 6.500% |
655,555 (+21.15%) |
Filing History |
| 2024-02-13 11:57 am Purchase |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
JANUS HENDERSON GROUP PLC JHG |
3,994,785 6.900% |
350,830 (+9.63%) |
Filing History |
| 2024-02-12 06:12 am Sale |
2023-12-31 | 13G | Ascendis Pharma A/S ASND |
Artisan Partners Asset Management Inc. | 5,749,227 10.000% |
-1,171,129 (-16.92%) |
Filing History |